{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:44:28Z","timestamp":1791031468181,"version":"4.1.0"},"reference-count":51,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,9,1]]},"abstract":"<jats:p>Objective. Neonatal candidemia is an increasing cause of infant morbidity and mortality. We evaluated the current medical literature in an effort to critique the literature and to document the reported prevalences of end-organ damage after neonatal candidemia.<\/jats:p><jats:p>Methods. We analyzed all peer-reviewed articles of neonatal candidemia published in the English language; inclusion criteria included a cohort limited to all neonatal intensive care unit admissions or all episodes of candidemia in neonates. Articles that also incorporated older patients, did not define a numerator and a denominator for at least 1 form of end-organ damage, included patients from other reports, or did not include all episodes of candidemia in the source population were excluded from the analysis.<\/jats:p><jats:p>Results. Thirty-four articles reported episodes of candidemia and mortality; 21 articles reported prevalence for at least 1 form of end-organ damage. Only 4 (19%) of 21 articles reported prevalence for &amp;gt;4 forms of end-organ damage from the following list: endophthalmitis, meningitis, brain parenchyma invasion, endocarditis, renal abscesses, positive cultures from other normally sterile body fluids, or hepatosplenic abscesses. The median reported prevalence of endophthalmitis was 3% (interquartile range [IQR]: 0%\u201317%), of meningitis was 15% (IQR: 3%\u201323%), of brain abscess or ventriculitis was 4% (IQR: 3%\u201321%), of endocarditis was 5% (IQR: 0%\u201313%), of positive renal ultrasound was 5% (IQR: 0%\u201314%), and of positive urine culture was 61% (IQR: 40%\u201376%). The medical literature concerning end-organ evaluation after episodes of neonatal candidemia is heterogeneous and consists largely of single-center retrospective studies. Year that the data were collected and prevalence of neonates infected with Candida albicans were associated with observed heterogeneity.<\/jats:p><jats:p>Conclusions. Given the heterogeneity of the medical literature, precise estimates of the frequencies of end-organ damage are not possible and a prospective multicenter trial is warranted, but the data from the published literature suggest that the prevalence of neonates with end-organ damage not only is greater than 0 but also is high enough that until such a prospective trial is completed, end-organ studies should be considered before the conclusion of antifungal therapy.<\/jats:p>","DOI":"10.1542\/peds.112.3.634","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"634-640","source":"Crossref","is-referenced-by-count":199,"title":["Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-analytic Techniques"],"prefix":"10.1542","volume":"112","author":[{"suffix":"Jr","given":"Daniel K.","family":"Benjamin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"},{"name":"Duke University Clinical Research Institute, Durham, North Carolina"},{"name":"University of North Carolina School of Public Health, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Poole","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Public Health, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Steinbach","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"},{"name":"Duke University Mycology Research Unit, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L.","family":"Rowen","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,9,1]]},"reference":[{"key":"2021120820245360800_R1","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics.2002;110:285\u2013291","DOI":"10.1542\/peds.110.2.285"},{"key":"2021120820245360800_R2","doi-asserted-by":"crossref","unstructured":"Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis.1992;15:414\u2013421","DOI":"10.1093\/clind\/15.3.414"},{"key":"2021120820245360800_R3","doi-asserted-by":"crossref","unstructured":"Klein JJ, Watanakunakorn C. Hospital-acquired fungemia: its natural course and clinical significance. Am J Med.1979;67:51\u201358","DOI":"10.1016\/0002-9343(79)90073-1"},{"key":"2021120820245360800_R4","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr.1996;129:63\u201371","DOI":"10.1016\/S0022-3476(96)70191-9"},{"key":"2021120820245360800_R5","doi-asserted-by":"crossref","unstructured":"Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med.1988;148:2642\u20132645","DOI":"10.1001\/archinte.148.12.2642"},{"key":"2021120820245360800_R6","doi-asserted-by":"crossref","unstructured":"Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med.2001;345:1660\u20131666","DOI":"10.1056\/NEJMoa010494"},{"key":"2021120820245360800_R7","doi-asserted-by":"crossref","unstructured":"Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics.1984;73:144\u2013152","DOI":"10.1542\/peds.73.2.144"},{"key":"2021120820245360800_R8","doi-asserted-by":"crossref","unstructured":"Baley JE, Silverman RA. Systemic candidiasis: cutaneous manifestations in low birth weight infants. Pediatrics.1988;82:211\u2013215","DOI":"10.1542\/peds.82.2.211"},{"key":"2021120820245360800_R9","doi-asserted-by":"crossref","unstructured":"Chapman RL, Faix RG. Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J.2000;19:822\u2013827","DOI":"10.1097\/00006454-200009000-00003"},{"key":"2021120820245360800_R10","doi-asserted-by":"crossref","unstructured":"Faix RG. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr.1984;105:616\u2013622","DOI":"10.1016\/S0022-3476(84)80433-3"},{"key":"2021120820245360800_R11","doi-asserted-by":"crossref","unstructured":"Friedman S, Richardson SE, Jacobs SE, O\u2019 Brien K. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J.2000;19:499\u2013504","DOI":"10.1097\/00006454-200006000-00002"},{"key":"2021120820245360800_R12","doi-asserted-by":"crossref","unstructured":"Noyola DE, Fernandez M, Moylett EH, Baker CJ. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis.2001;32:1018\u20131023","DOI":"10.1086\/319601"},{"key":"2021120820245360800_R13","doi-asserted-by":"crossref","unstructured":"Benjamin DK Jr, Ross K, McKinney RE Jr, Benjamin DK, Auten R, Fisher RG. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics.2000;106:712\u2013718","DOI":"10.1542\/peds.106.4.712"},{"key":"2021120820245360800_R14","doi-asserted-by":"crossref","unstructured":"Butler KM, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J.1990;9:51\u201356","DOI":"10.1097\/00006454-199001000-00012"},{"key":"2021120820245360800_R15","doi-asserted-by":"crossref","unstructured":"El-Masry F, Neal TJ, Subhedar NV. Risk factors for invasive fungal infection in neonates. Acta Paediatr.2002;91:198\u2013202","DOI":"10.1111\/j.1651-2227.2002.tb01695.x"},{"key":"2021120820245360800_R16","doi-asserted-by":"crossref","unstructured":"el-Mohandes AE, Johnson-Robbins L, Keiser JF, Simmens SJ, Aure MV. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J.1994;13:520\u2013524","DOI":"10.1097\/00006454-199406000-00011"},{"key":"2021120820245360800_R17","doi-asserted-by":"crossref","unstructured":"Glick C, Graves GR, Feldman S. Neonatal fungemia and amphotericin B. South Med J.1993;86:1368\u20131371","DOI":"10.1097\/00007611-199312000-00009"},{"key":"2021120820245360800_R18","doi-asserted-by":"crossref","unstructured":"Huttova M, Hartmanova I, Kralinsky K, et al. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Pediatr Infect Dis J.1998;17:1012\u20131015","DOI":"10.1097\/00006454-199811000-00010"},{"key":"2021120820245360800_R19","doi-asserted-by":"crossref","unstructured":"Johnson DE, Thompson TR, Green TP, Ferrieri P. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams). Pediatrics.1984;73:138\u2013143","DOI":"10.1542\/peds.73.2.138"},{"key":"2021120820245360800_R20","doi-asserted-by":"crossref","unstructured":"Lee BE, Cheung PY, Robinson JL, Evanochko C, Robertson CM. Comparative study of mortality and morbidity in premature infants (birth weight, &lt;1,250 g) with candidemia or candidal meningitis. Clin Infect Dis.1998;27:559\u2013565","DOI":"10.1086\/514712"},{"key":"2021120820245360800_R21","doi-asserted-by":"crossref","unstructured":"Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis.1992;14:485\u2013491","DOI":"10.1093\/clinids\/14.2.485"},{"key":"2021120820245360800_R22","doi-asserted-by":"crossref","unstructured":"Mittal M, Dhanireddy R, Higgins RD. Candida sepsis and association with retinopathy of prematurity. Pediatrics.1998;101:654\u2013657","DOI":"10.1542\/peds.101.4.654"},{"key":"2021120820245360800_R23","doi-asserted-by":"crossref","unstructured":"Sigmundsdottir G, Christensson B, Bjorklund LJ, Hakansson K, Pehrson C, Larsson L. Urine D-arabinitol\/L-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants. J Clin Microbiol.2000;38:3039\u20133042","DOI":"10.1128\/JCM.38.8.3039-3042.2000"},{"key":"2021120820245360800_R24","doi-asserted-by":"crossref","unstructured":"Smith H, Congdon P. Neonatal systemic candidiasis. Arch Dis Child.1985;60:365\u2013369","DOI":"10.1136\/adc.60.4.365"},{"key":"2021120820245360800_R25","doi-asserted-by":"crossref","unstructured":"Weese-Mayer D, Wheeler Fondriest D, Brouillette RT, Shulman ST. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J.1987;6:190\u2013196","DOI":"10.1097\/00006454-198702000-00009"},{"key":"2021120820245360800_R26","doi-asserted-by":"crossref","unstructured":"Vaudry WL, Tierney AJ, Wenman WM. Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis.1988;158:1375\u20131379","DOI":"10.1093\/infdis\/158.6.1375"},{"key":"2021120820245360800_R27","doi-asserted-by":"crossref","unstructured":"Rowen JL, Tate JM. Management of neonatal candidiasis. Pediatr Infect Dis J.1998;17:1007\u20131011","DOI":"10.1097\/00006454-199811000-00008"},{"key":"2021120820245360800_R28","doi-asserted-by":"crossref","unstructured":"Makhoul IR, Kassis I, Smolkin T, Tamir A, Sujov P. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics.2001;107:61\u201366","DOI":"10.1542\/peds.107.1.61"},{"key":"2021120820245360800_R29","doi-asserted-by":"crossref","unstructured":"Huang YC, Li CC, Lin TY, et al. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J.1998;17:819\u2013822","DOI":"10.1097\/00006454-199809000-00014"},{"key":"2021120820245360800_R30","doi-asserted-by":"crossref","unstructured":"Huang YC, Lin TY, Lien RI, et al. Candidaemia in special care nurseries: comparison of albicans and parapsilosis infection. J Infect.2000;40:171","DOI":"10.1053\/jinf.2000.0638"},{"key":"2021120820245360800_R31","doi-asserted-by":"crossref","unstructured":"Huang YC, Lin TY, Lien RI, et al. Fluconazole therapy in neonatal candidemia. Am J Perinatol.2000;17:411\u2013415","DOI":"10.1055\/s-2000-13454"},{"key":"2021120820245360800_R32","doi-asserted-by":"crossref","unstructured":"Blair A, Burg J, Foran J, Gibb H, et al. Guidelines for application of meta-analysis in environmental epidemiology. Regul Toxicol Pharmacol.1995;22:189\u2013197","DOI":"10.1006\/rtph.1995.1084"},{"key":"2021120820245360800_R33","doi-asserted-by":"crossref","unstructured":"Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systemic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol.1995;48:167\u2013171","DOI":"10.1016\/0895-4356(94)00172-M"},{"key":"2021120820245360800_R34","doi-asserted-by":"crossref","unstructured":"Dickerson K, Berlin JA. Meta-analysis: state of science. Epidemiol Rev.1992;14:154\u2013176","DOI":"10.1093\/oxfordjournals.epirev.a036084"},{"key":"2021120820245360800_R35","doi-asserted-by":"crossref","unstructured":"Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev.1987;9:1\u201330","DOI":"10.1093\/oxfordjournals.epirev.a036298"},{"key":"2021120820245360800_R36","doi-asserted-by":"crossref","unstructured":"Egger M, Schneider M, Smith GD. Spurious precision? Meta-analysis of observational studies. Br Med J.1998;316:140\u2013144","DOI":"10.1136\/bmj.316.7125.140"},{"key":"2021120820245360800_R37","doi-asserted-by":"crossref","unstructured":"Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology.1993;4:295\u2013302","DOI":"10.1097\/00001648-199307000-00004"},{"key":"2021120820245360800_R38","doi-asserted-by":"crossref","unstructured":"Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med.1999;18:2693\u20132708","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V"},{"key":"2021120820245360800_R39","unstructured":"Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons; 1981:64"},{"key":"2021120820245360800_R40","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank order correlation test for publication bias. Biometrics.1994;50:1088\u20131101","DOI":"10.2307\/2533446"},{"key":"2021120820245360800_R41","doi-asserted-by":"crossref","unstructured":"Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis.1990;12:308\u2013329","DOI":"10.1093\/clinids\/12.2.308"},{"key":"2021120820245360800_R42","doi-asserted-by":"crossref","unstructured":"Baley JE, Meyers C, Kliegman RM, Jacobs MR, Blumer JL. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr.1990;116:791\u2013797","DOI":"10.1016\/S0022-3476(05)82674-5"},{"key":"2021120820245360800_R43","doi-asserted-by":"crossref","unstructured":"Fernandez M, Moylett EH, Noyola DE, Baker CJ. Candidal meningitis in neonates: a 10-year review. Clin Infect Dis.2000;31:458\u2013463","DOI":"10.1086\/313973"},{"key":"2021120820245360800_R44","doi-asserted-by":"crossref","unstructured":"Annable WL, Kachmer ML, DiMarco M, DeSantis D. Long-term follow-up of Candida endophthalmitis in the premature infant. J Pediatr Ophthalmol Strabismus.1990;27:103\u2013106","DOI":"10.3928\/0191-3913-19900301-12"},{"key":"2021120820245360800_R45","doi-asserted-by":"crossref","unstructured":"Karlowicz MG, Giannone PJ, Pestian J, Morrow AL, Shults J. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (\u22641000 g) neonates?Pediatrics.2000;105:1036\u20131040","DOI":"10.1542\/peds.105.5.1036"},{"key":"2021120820245360800_R46","unstructured":"Deconinck H, Libert J, Biarent D, Caspers-Velu LE. Endogenous mycotic endophthalmitis in an infant. Bull Soc Belge Ophthalmol.1991;241:77\u201383"},{"key":"2021120820245360800_R47","doi-asserted-by":"crossref","unstructured":"Stern JH, Calvano C, Simon JW. Recurrent endogenous candidal endophthalmitis in a premature infant. J AAPOS.2001;5:50\u201351","DOI":"10.1067\/mpa.2001.111136"},{"key":"2021120820245360800_R48","doi-asserted-by":"crossref","unstructured":"Noyola DE, Bohra L, Paysse EA, Fernandez M, Coats DK. Association of candidemia and retinopathy of prematurity in very low birthweight infants. Ophthalmology.2002;109:80\u201384","DOI":"10.1016\/S0161-6420(01)00841-7"},{"key":"2021120820245360800_R49","doi-asserted-by":"crossref","unstructured":"Rex JH, Walsh TJ, Soebl JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis.2000;30:662\u2013678","DOI":"10.1086\/313749"},{"key":"2021120820245360800_R50","doi-asserted-by":"crossref","unstructured":"Bryant K, Maxfield C, Rabalais G. Renal candidiasis in neonates with candiduria. Pediatr Infect Dis J.1999;18:959\u2013963","DOI":"10.1097\/00006454-199911000-00004"},{"key":"2021120820245360800_R51","doi-asserted-by":"crossref","unstructured":"Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis J.2000;19:319\u2013332","DOI":"10.1097\/00006454-200004000-00011"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/3\/634\/1006592\/pe0903000634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/3\/634\/1006592\/pe0903000634.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:37:26Z","timestamp":1682746646000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/112\/3\/634\/28671\/Neonatal-Candidemia-and-End-Organ-Damage-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,1]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2003,9,1]]},"published-print":{"date-parts":[[2003,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.112.3.634","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,1]]}}}